These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18184366)

  • 1. Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment.
    Bayer TA; Wirths O
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():6-11. PubMed ID: 18184366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease.
    Wirths O; Breyhan H; Schäfer S; Roth C; Bayer TA
    Neurobiol Aging; 2008 Jun; 29(6):891-901. PubMed ID: 17215062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse model.
    Bayer TA; Breyhan H; Duan K; Rettig J; Wirths O
    Neurodegener Dis; 2008; 5(3-4):140-2. PubMed ID: 18322372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
    Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA
    Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
    Breyhan H; Wirths O; Duan K; Marcello A; Rettig J; Bayer TA
    Acta Neuropathol; 2009 Jun; 117(6):677-85. PubMed ID: 19387667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
    Wirths O; Breyhan H; Marcello A; Cotel MC; Brück W; Bayer TA
    Neurobiol Aging; 2010 May; 31(5):747-57. PubMed ID: 18657882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Wirths O; Weis J; Szczygielski J; Multhaup G; Bayer TA
    Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.
    Jawhar S; Trawicka A; Jenneckens C; Bayer TA; Wirths O
    Neurobiol Aging; 2012 Jan; 33(1):196.e29-40. PubMed ID: 20619937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.
    Christensen DZ; Bayer TA; Wirths O
    Neurobiol Aging; 2010 Jul; 31(7):1153-63. PubMed ID: 18771817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent axonal degeneration in an Alzheimer mouse model.
    Wirths O; Weis J; Kayed R; Saido TC; Bayer TA
    Neurobiol Aging; 2007 Nov; 28(11):1689-99. PubMed ID: 16963164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice.
    Cotel MC; Bayer TA; Wirths O
    Brain Res; 2008 Jul; 1222():207-13. PubMed ID: 18585693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
    J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
    Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
    Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
    Weissmann R; Hüttenrauch M; Kacprowski T; Bouter Y; Pradier L; Bayer TA; Kuss AW; Wirths O
    J Alzheimers Dis; 2016; 50(2):397-409. PubMed ID: 26639971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice.
    Shie FS; LeBoeuf RC; Jin LW
    Neuroreport; 2003 Jan; 14(1):123-9. PubMed ID: 12544843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice.
    Cotel MC; Jawhar S; Christensen DZ; Bayer TA; Wirths O
    Neurobiol Aging; 2012 Jan; 33(1):96-107. PubMed ID: 20359774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.
    Wirths O; Multhaup G; Bayer TA
    J Neurochem; 2004 Nov; 91(3):513-20. PubMed ID: 15485483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.
    Philipson O; Lannfelt L; Nilsson LN
    FEBS Lett; 2009 Sep; 583(18):3021-6. PubMed ID: 19683527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
    Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP
    Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
    Götz J; Ittner LM; Kins S
    J Neurochem; 2006 Aug; 98(4):993-1006. PubMed ID: 16787410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.